financetom
Business
financetom
/
Business
/
GRI Bio Gets Japan Patent for Natural Killer T Cell Modulators to Prevent, Treat Inflammatory Diseases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GRI Bio Gets Japan Patent for Natural Killer T Cell Modulators to Prevent, Treat Inflammatory Diseases
Oct 2, 2024 11:30 PM

09:24 AM EDT, 09/30/2024 (MT Newswires) -- GRI Bio ( GRI ) said Monday it has received a "decision to grant" notice from Japan's Patent Office for a patent application covering the use of natural killer T cell modulators to prevent and treat inflammatory diseases.

The patent covers claims, which include compositions and methods, for modulating type 2 and/or type 1 invariant natural killer T cells to prevent and treat the conditions, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
India orders unusual recall of reports on Apple antitrust probe
India orders unusual recall of reports on Apple antitrust probe
Aug 13, 2024
* Apple ( AAPL ) faces antitrust battles in India, elsewhere * Relief for Apple ( AAPL ) as India recalls investigation reports * Apple ( AAPL ) said confidential information was given to opponents * Revision of reports can delay probe, sources say (Adds lawyer comments, details; paragraphs 10-18) By Aditya Kalra NEW DELHI, Aug 13 (Reuters) - India's...
Atlassian Insider Sold Shares Worth $1,122,509, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,122,509, According to a Recent SEC Filing
Aug 13, 2024
03:17 AM EDT, 08/13/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Co-Chief Executive Officer, Co-Founder, on August 09, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,122,509. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 278,180 shares of the company, with 278,180 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024006152/xslF345X03/primarydocument.xml Price: 140.00, Change:...
Atlassian Insider Sold Shares Worth $1,122,507, According to a Recent SEC Filing
Atlassian Insider Sold Shares Worth $1,122,507, According to a Recent SEC Filing
Aug 13, 2024
03:17 AM EDT, 08/13/2024 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, Co-Chief Executive Officer, Co-Founder, on August 09, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,122,507. Following the Form 4 filing with the SEC, Farquhar has control over a total of 278,180 shares of the company, with 278,180 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024006151/xslF345X03/primarydocument.xml Price: 140.00, Change:...
Snap-on Insider Sold Shares Worth $6,493,809, According to a Recent SEC Filing
Snap-on Insider Sold Shares Worth $6,493,809, According to a Recent SEC Filing
Aug 13, 2024
03:18 AM EDT, 08/13/2024 (MT Newswires) -- Nicholas T Pinchuk, Director, Chairman, President and Chief Executive Officer, on August 12, 2024, sold 24,145 shares in Snap-on (SNA) for $6,493,809. Following the Form 4 filing with the SEC, Pinchuk has control over a total of 759,857 shares of the company, with 759,019 shares held directly and 837 controlled indirectly. SEC Filing:...
Copyright 2023-2024 - www.financetom.com All Rights Reserved